Furthermore, in two mouse models of colitis-associated CRC, PINK1 disruption increased TNFα, IL-1β, IL-6, and IFN-β mRNA expression, and increased colon tumorigenesis, suggesting a role for PINK1 as a tumor inhibitor in CRC [191,192]. Here, PINK1 is linked to neoplasm.